FdaApplication
ANDA 212025
Identifiers
- fda_app_no: ANDA212025
Properties
| Property | Value |
|---|---|
| applicant_name | TP ANDA HOLDINGS LLC |
| application_type | ANDA |
| approval_date | 2022-02-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| APOMORPHINE HYDROCHLORIDE | APOMORPHINE HYDROCHLORIDE | 30MG/3ML (10MG/ML) | INJECTABLE;SUBCUTANEOUS |
1 product